Skip to main content
Image coming soon

Board-Level AI in Pharmaceutical R&D Operations for Audit Teams

$199.00
Adding to cart… The item has been added

A tailored course, built for your situation

Board-Level AI in Pharmaceutical R&D Operations for Audit Teams

Master the governance, risk, and compliance frameworks powering AI-augmented drug development oversight

$199 one-time
24-hour access provisioning 30-day money-back guarantee Hand-built implementation playbook
12 modules. 12 chapters per module. 144 chapters total.
12 modules, each with 12 chapters (144 chapters total), text-based, plus downloadable templates and a hand-built implementation playbook delivered alongside course access.
Audit teams face rising pressure to validate AI systems used in drug discovery and clinical trials, without clear frameworks or implementation tools.

The situation this course is for

As AI accelerates pharmaceutical R&D, audit functions are expected to provide assurance on complex, opaque systems. Traditional audit approaches fall short when assessing algorithmic risk, data provenance, and model lifecycle governance, especially under board-level scrutiny. Professionals lack structured, actionable training to bridge compliance standards with technical AI realities.

Who this is for

Compliance officers, internal auditors, and risk professionals in life sciences organizations who are stepping into strategic roles involving AI governance and digital transformation oversight.

Who this is not for

This course is not for data scientists building AI models, software engineers implementing pipelines, or executives seeking high-level summaries without operational detail.

What you walk away with

  • Interpret AI model risk frameworks within pharmaceutical R&D contexts
  • Evaluate data governance and auditability of AI-driven clinical trial systems
  • Align audit plans with emerging regulatory expectations for algorithmic transparency
  • Lead cross-functional reviews of AI use cases in drug discovery and development
  • Deploy a customized implementation playbook to standardize AI audit practices

The 12 modules (with all 144 chapters)

Module 1. AI in Pharmaceutical R&D: Landscape and Strategic Drivers
Understand the shift toward AI-augmented drug development and its implications for audit functions.
12 chapters in this module
  1. Overview of AI applications in drug discovery
  2. Trends in AI-powered clinical trial design
  3. Regulatory incentives for AI adoption
  4. Investment patterns in pharma AI startups
  5. Strategic priorities shaping R&D transformation
  6. Board-level discussions on innovation velocity
  7. Key performance indicators for AI projects
  8. Benchmarking AI maturity across organizations
  9. Stakeholder mapping in AI-driven R&D
  10. Ethical considerations in early-stage AI use
  11. Public-private partnerships in AI research
  12. Future outlook for AI in life sciences
Module 2. Governance Models for AI in Regulated Environments
Explore governance structures that ensure accountability and compliance in AI deployment.
12 chapters in this module
  1. Principles of responsible AI in healthcare
  2. Establishing AI oversight committees
  3. Roles and responsibilities in AI governance
  4. Integrating AI governance into enterprise risk management
  5. Board reporting mechanisms for AI initiatives
  6. Policy development for AI use cases
  7. Vendor oversight in AI procurement
  8. Third-party audit coordination
  9. Documentation standards for AI systems
  10. Change management for AI governance rollout
  11. Training programs for governance stakeholders
  12. Continuous monitoring of governance effectiveness
Module 3. Model Risk Management in Life Sciences
Apply model risk principles specific to pharmaceutical AI applications.
12 chapters in this module
  1. Foundations of model risk management
  2. Classifying AI models by risk tier
  3. Validation requirements for predictive models
  4. Backtesting strategies for AI outputs
  5. Sensitivity analysis in drug response models
  6. Handling model drift in real-world data
  7. Model inventory and registry design
  8. Independent review processes
  9. Documentation for regulatory exams
  10. Stress testing AI under edge cases
  11. Model decommissioning protocols
  12. Integration with pharmacovigilance systems
Module 4. Data Governance and Provenance in AI Systems
Ensure data integrity and traceability across AI-driven R&D workflows.
12 chapters in this module
  1. Data lifecycle management in AI projects
  2. Source verification for clinical datasets
  3. Metadata standards for AI training data
  4. Handling multimodal data in drug discovery
  5. Data lineage tracking tools and techniques
  6. Consent and privacy in genomic data use
  7. Data quality metrics for AI readiness
  8. Bias detection in training populations
  9. Data access controls and audit trails
  10. Cross-border data transfer compliance
  11. Data retention and archival policies
  12. Reproducibility standards for AI research
Module 5. Audit Frameworks for AI-Augmented Clinical Trials
Adapt audit methodologies to assess AI use in trial design, recruitment, and monitoring.
12 chapters in this module
  1. AI applications in patient recruitment
  2. Algorithmic bias in eligibility screening
  3. Endpoint prediction models and validation
  4. Remote monitoring via AI-powered sensors
  5. Adverse event detection algorithms
  6. Real-time data analytics in trials
  7. Audit planning for adaptive trial designs
  8. Assessing algorithm transparency
  9. Vendor-managed AI platforms
  10. Protocol deviation tracking with AI
  11. Informed consent in AI-mediated trials
  12. Audit reporting on AI performance
Module 6. Regulatory Alignment and Compliance Standards
Navigate evolving regulations impacting AI in pharmaceutical development.
12 chapters in this module
  1. FDA guidance on AI/ML in medical products
  2. EMA perspectives on algorithmic transparency
  3. ICH frameworks and potential extensions
  4. GLP, GCP, and GMP implications for AI
  5. 21 CFR Part 11 and electronic records
  6. AI in pharmacovigilance and signal detection
  7. Labeling requirements for AI-informed decisions
  8. Post-market surveillance with AI tools
  9. Harmonization efforts across jurisdictions
  10. Inspection readiness for AI systems
  11. Responding to regulatory inquiries
  12. Proactive compliance strategy development
Module 7. Algorithmic Accountability and Explainability
Evaluate the interpretability and fairness of AI models used in R&D.
12 chapters in this module
  1. Explainable AI (XAI) techniques overview
  2. SHAP, LIME, and other interpretability tools
  3. Documentation of model rationale
  4. Stakeholder communication of AI decisions
  5. Fairness metrics in clinical applications
  6. Disparities in AI performance across populations
  7. Bias mitigation strategies
  8. Human-in-the-loop validation
  9. Audit trails for algorithmic decisions
  10. Redress mechanisms for affected parties
  11. Ethics board engagement on AI use
  12. Transparency reporting templates
Module 8. Validation and Verification of AI Systems
Implement rigorous testing protocols for AI models in regulated settings.
12 chapters in this module
  1. Validation vs. verification in AI context
  2. Test planning for machine learning models
  3. Unit testing for AI components
  4. Integration testing with legacy systems
  5. Performance benchmarking against baselines
  6. Robustness testing under noise conditions
  7. Edge case identification and handling
  8. Reproducibility of training pipelines
  9. Version control for models and data
  10. Audit readiness for validation artifacts
  11. Third-party validation coordination
  12. Ongoing validation during model lifecycle
Module 9. Cybersecurity and AI System Integrity
Protect AI systems from threats that could compromise R&D integrity.
12 chapters in this module
  1. Threat modeling for AI architectures
  2. Adversarial attacks on machine learning models
  3. Data poisoning and evasion techniques
  4. Secure model deployment practices
  5. Access control for AI platforms
  6. Encryption of model weights and data
  7. Incident response for AI disruptions
  8. Penetration testing AI systems
  9. Supply chain risks in AI tooling
  10. Monitoring for anomalous behavior
  11. Compliance with cybersecurity frameworks
  12. Coordination with IT security teams
Module 10. Cross-Functional Collaboration in AI Audits
Lead audits that require coordination across technical, clinical, and regulatory teams.
12 chapters in this module
  1. Stakeholder identification in AI projects
  2. Facilitating technical-to-audit translation
  3. Building trust with data science teams
  4. Managing conflicting priorities in R&D
  5. Communication strategies for non-technical audiences
  6. Joint review sessions with development teams
  7. Escalation pathways for audit findings
  8. Documenting cross-functional agreements
  9. Conflict resolution in audit contexts
  10. Feedback loops for process improvement
  11. Knowledge transfer between teams
  12. Sustaining collaboration post-audit
Module 11. Reporting and Communication at the Board Level
Craft clear, actionable insights for executive and board audiences.
12 chapters in this module
  1. Understanding board expectations on AI
  2. Risk appetite frameworks for AI initiatives
  3. Key risk indicators for AI oversight
  4. Visualizing AI risk and performance data
  5. Narrative construction for audit summaries
  6. Balancing technical depth and strategic focus
  7. Preparing for board Q&A sessions
  8. Linking AI audits to business outcomes
  9. Scenario planning for AI risks
  10. Benchmarking against industry peers
  11. Presenting mitigation strategies
  12. Follow-up reporting on action items
Module 12. Implementation Playbook and Continuous Improvement
Deploy a customized framework for ongoing AI audit excellence.
12 chapters in this module
  1. Assessing organizational readiness for AI audits
  2. Gap analysis against best practices
  3. Prioritizing high-impact audit areas
  4. Resource planning for AI-focused audits
  5. Developing internal expertise pathways
  6. Vendor selection for AI audit support
  7. Tooling recommendations for automation
  8. Creating audit templates and checklists
  9. Pilot program design and execution
  10. Measuring impact of AI audit improvements
  11. Feedback integration from stakeholders
  12. Roadmap for continuous capability building

How this maps to your situation

  • Preparing for first AI audit in drug development pipeline
  • Responding to increased board scrutiny of AI projects
  • Aligning internal audit function with AI transformation strategy
  • Building credibility in cross-functional AI governance forums

Before vs. after

Before
Uncertain how to assess AI systems in R&D, relying on general audit principles that miss critical technical and regulatory nuances.
After
Confidently lead AI audits with a structured, implementation-ready approach aligned to pharma-specific risks and board expectations.

What's included with your purchase

  • 12 modules with 12 chapters each (144 chapters)
  • Downloadable templates and worked examples for every module
  • Hand-built implementation playbook delivered alongside course access
  • 30-day money-back guarantee

Delivery and format

  • Course and learning environment access provisioned within 24 hours of purchase
  • Hand-built implementation playbook delivered alongside course access

Format: Text-based modules and chapters in the Art of Service learning environment, plus downloadable templates and worked examples for every chapter, plus the hand-built implementation playbook delivered alongside course access.

Time investment: Approximately 40, 50 hours of self-paced learning, designed to fit around professional responsibilities.

If nothing changes
Without structured training, audit professionals may overlook critical failure points in AI systems, leading to undetected biases, compliance gaps, or loss of stakeholder trust during high-visibility R&D reviews.

How this compares to the alternatives

Unlike generic AI ethics courses or high-level executive briefings, this program delivers implementation-grade knowledge specific to pharmaceutical R&D audit challenges, with actionable tools and real-world examples not found in academic or vendor-provided materials.

Frequently asked

Who is this course designed for?
Compliance officers, internal auditors, and risk professionals in life sciences organizations who need to assess AI systems in drug development with technical precision and regulatory alignment.
How is the course structured?
12 modules, each containing 12 chapters (144 chapters total).
Is there a certificate upon completion?
Yes, a certificate of completion is awarded after finishing all modules and passing the final assessment.
$199 one-time. Approximately 40, 50 hours of self-paced learning, designed to fit around professional responsibilities..

Within 24 hours your account in the learning environment is provisioned and the tailored implementation playbook is delivered alongside it.

30-day money-back guarantee· 144 chapters· Hand-built playbook included· Account access within 24 hours
!